Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) EBIT Margin: 2017-2025

Historic EBIT Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to 13.74%.

  • Organogenesis Holdings' EBIT Margin rose 832.00% to 13.74% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.80%, marking a year-over-year increase of 101.00%. This contributed to the annual value of -0.27% for FY2024, which is 316.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its EBIT Margin stood at 13.74% for Q3 2025, which was up 210.34% from -12.45% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' EBIT Margin registered a high of 19.15% during Q2 2021, and its lowest value of -30.85% during Q1 2025.
  • Moreover, its 3-year median value for EBIT Margin was -1.27% (2023), whereas its average is -1.77%.
  • In the last 5 years, Organogenesis Holdings' EBIT Margin skyrocketed by 3,674bps in 2021 and then tumbled by 2,735bps in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' EBIT Margin stood at 15.45% in 2021, then crashed by 790bps to 7.55% in 2022, then crashed by 882bps to -1.27% in 2023, then surged by 934bps to 8.07% in 2024, then soared by 832bps to 13.74% in 2025.
  • Its EBIT Margin stands at 13.74% for Q3 2025, versus -12.45% for Q2 2025 and -30.85% for Q1 2025.